Kamal Adawi Exagen Inc. (XGN) insider trading activity

Kamal Adawi is CFO and Corporate Secretary of EXAGEN INC.. Currently has a direct ownership of 243,749 shares of XGN, which is worth approximately $443,623. The most recent transaction as insider was on Mar 04, 2024, when has been sold 12,784 shares (Common Stock) at a price of $1.91 per share, resulting in proceeds of $24,417. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 244K

0% 3M change

29.47% 12M change

Total Value Held $443,623

Kamal Adawi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2024	SELL Open market or private sale	$24,417 $1.91 p/Share	12,784 Reduced 4.98%	243,749 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	75,000 Added 22.62%	256,533 Common Stock
Feb 06 2024	SELL Open market or private sale	$13,139 $1.95 p/Share	6,738 Reduced 3.58%	181,533 Common Stock
Mar 02 2023	SELL Open market or private sale	$8,434 $2.3 p/Share	3,667 Reduced 1.91%	188,271 Common Stock
Feb 27 2023	BUY Grant, award, or other acquisition	-	100,000 Added 34.25%	191,938 Common Stock
Feb 08 2023	SELL Open market or private sale	$15,658 $2.69 p/Share	5,821 Reduced 5.95%	91,938 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$23,076 $7.12 p/Share	3,241 Reduced 3.21%	97,759 Common Stock

Feb 04 2022	BUY Grant, award, or other acquisition	-	63,500 Added 38.6%	101,000 Common Stock
Feb 23 2021	BUY Grant, award, or other acquisition	-	37,500 Added 50.0%	37,500 Common Stock

Kamal Adawi

CFO and Corporate Secretary

Vista, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XGN shares.

Notify only if

Value

Insider Trading

Get notified when an Exagen Inc. insider buys or sells XGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXAGEN INC.

Track Activities on XGN

Account